Carbon-ion beam treatment induces systemic antitumor immunity against murine squamous cell carcinoma

Cancer

Volumn 116, Issue 15, 2010, Pages 3740-3748

  Matsunaga, Akinao ^a   Ueda, Yasuji ^a   Yamada, Shigeru ^b   Harada, Yui ^a   Shimada, Hideaki ^a   Hasegawa, Mamoru ^c   Tsujii, Hirohiko ^b   Ochiai, Takenori ^a   Yonemitsu, Yoshikazu ^a,d  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^c University of Tokyo   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

Antitumor immunity; Carbon ion beam; Immunotherapy; Squamous cell carcinoma

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEAM THERAPY; CANCER GRAFT; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CARBON ION BEAM THERAPY; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FEMALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY;

ANIMALS; CARBON; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DENDRITIC CELLS; FEMALE; GRAFT REJECTION; IMMUNOTHERAPY, ADOPTIVE; IONS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, NUDE; NEOPLASM TRANSPLANTATION; T-LYMPHOCYTES, CYTOTOXIC;

EID: 77955404492     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25134     Document Type: Article

References (24)

1. Schulz-Ertner D, Tsujii H. Particle radiation therapy using proton and heavier ion beams. J Clin Oncol. 2007;25:953-964. (Pubitemid 350002861)
2. Lee R, Yamada S, Yamamoto N, et al. Chromosomal aberrations in lymphocytes of lung cancer patients treated with carbon ions. J Radiat Res. 2004;45:195-199. (Pubitemid 39237120)
3. Iwakawa M, Noda S, Yamada S, et al. Analysis of nongenetic risk factors for adverse skin reactions to radiotherapy among 284 breast cancer patients. Breast Cancer. 2006;13:300-307.
4. Murakami M, Eguchi-Kasai K, Sato K, Minohara S, Yatagai F, Kanai T. Differences in heavy-ion-induced DNA double-strand breaks in a mouse DNA repair-deficient mutant cell line (SL3-147) before and after chromatin proteolysis. J Radiat Res. 1995;36:258-264.
5. Heilmann J, Taucher-Scholz G, Haberer T, Scholz M, Kraft G. Measurement of intracellular DNA double-strand break induction and rejoining along the track of carbon and neon particle beams in water. Int J Radiat Oncol Biol Phys. 1996;34:599-608. (Pubitemid 26069191)
6. Ogata T, Teshima T, Kagawa K, et al. Particle irradiation suppresses metastatic potential of cancer cells. Cancer Res. 2005;65:113-120.
7. Ohuchida K, Mizumoto K, Murakami M, et al. Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions. Cancer Res. 2004;64:3215-3222.
8. Wild-Bode C, Weller M, Rimner A, Dichgans J, Wick W. Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma. Cancer Res. 2001;61:2744-2750. (Pubitemid 32685864)
9. Ohba K, Omagari K, Nakamura T, et al. Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis. Gut. 1998;43:575-577. (Pubitemid 28462047)
10. Nam SW, Han JY, Kim JI, et al. Spontaneous regression of a large hepatocellular carcinoma with skull metastasis. J Gastroenterol Hepatol. 2005;20:488-492. (Pubitemid 40469357)
11. Demaria S, Ng B, Devitt ML, et al. Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. Int J Radiat Oncol Biol Phys. 2004;58:862-870.
12. Kim KW, Kim SH, Shin JG, et al. Direct injection of immature dendritic cells into irradiated tumor induces efficient antitumor immunity. Int J Cancer. 2004;109:685-690.
13. Apetoh L, Ghiringhelli F, Tesniere A, et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med. 2007;13:1050-1058.
14. Shibata S, Okano S, Yonemitsu Y, et al. Induction of efficient antitumor immunity using dendritic cells activated by recombinant Sendai virus and its modulation by exogenous IFN-β gene. J Immunol. 2006;177:3564-3576. (Pubitemid 44359887)
15. Yoneyama Y, Ueda Y, Akutsu Y, et al. Development of immunostimulatory virotherapy using non-transmissible Sendai virus-activated dendritic cells. Biochem Biophys Res Commun. 2007;355:129-135. (Pubitemid 46298548)
16. den Brok MH, Sutmuller RP, Nierkens S, et al. Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity. Br J Cancer. 2006;95:896-905.
17. Strome SE, Voss S, Wilcox R, et al. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response. Cancer Res. 2002;62:1884-1889.
18. Santin AD, Hermonat PL, Ravaggi A, et al. The effects of irradiation on the expression of a tumour rejection antigen (heat shock protein gp96) in human cervical cancer. Int J Radiat Biol. 1998;73:699-704. (Pubitemid 28320040)
19. Basu S, Binder RJ, Suto R, Anderson KM, Srivastava PK. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappaB pathway. Int Immunol. 2000;12:1539-1546.
20. Ramirez SR, Singh-Jasuja H, Warger T, et al. Glycoprotein 96-activated dendritic cells induce a CD8-biased T cell response. Cell Stress Chaperones. 2005;10:221-229.
21. Kim SH, Wong RJ, Kooby DA, et al. Combination of mutated herpes simplex virus type 1 (G207 virus) with radiation for the treatment of squamous cell carcinoma of the head and neck. Eur J Cancer. 2005;41:313-322.
22. Kazama H, Ricci JE, Herndon JM, Hoppe G, Green DR, Ferguson TA. Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of highmobility group box-1 protein. Immunity. 2008;29:21-32. (Pubitemid 351952462)
23. Yamakawa N, Takahashi A, Mori E, et al. High LET radiation enhances apoptosis in mutated p53 cancer cells through caspase-9 activation. Cancer Sci. 2008;99:1455-1460.
24. Yahiro T, Masui S, Kubota N, Yamada K, Kobayashi A, Kishii K. Effects of hypoxic cell radiosensitizer doranidazole (PR-350) on the radioresponse of murine and human tumor cells in vitro and in vivo. J Radiat Res. 2005;46:363-372.